Analyze Diet
American journal of veterinary research2014; 75(7); 668-679; doi: 10.2460/ajvr.75.7.668

Effects of meloxicam and phenylbutazone on renal responses to furosemide, dobutamine, and exercise in horses.

Abstract: To compare the effects of 2 NSAIDs (phenylbutazone and meloxicam) on renal function in horses. Methods: 9 Thoroughbred or Standardbred mares (mean ± SD age, 5.22 ± 1.09 years [range, 2 to 12 years]; mean body weight, 470 ± 25 kg [range, 442 to 510 kg]). Methods: A randomized blinded placebo-controlled crossover study was conducted to examine the effects of treatment with phenylbutazone, meloxicam, or a placebo (control solution) on renal responses to the administration of furosemide, dobutamine, and exercise (15 minutes at 60% of maximum heart rate). Renal function was assessed by use of bilateral ureteral catheterization for simultaneous determination of creatinine clearance, sodium excretion, and urine flow rate. Results: Both phenylbutazone and meloxicam attenuated diuresis and natriuresis and reduced glomerular filtration rate, compared with results for the control solution, when horses were treated with furosemide. Mean arterial blood pressure, urine flow rate, and glomerular filtration rate were increased during or after (or both) dobutamine infusion. Both NSAIDs reduced urine flow rate and sodium excretion associated with dobutamine infusion and exercise but had no effect on glomerular filtration rate. Conclusions: Responses to meloxicam, a cyclooxygenase (COX)-2 preferential agent, appeared comparable to those detected after phenylbutazone treatment, which suggested that COX-2 was the mediator of prostanoid-induced changes to renal function in horses and indicated that COX-2-preferential agents would be likely to have adverse renal effects similar to those for nonselective COX inhibitors in volume-depleted horses.
Publication Date: 2014-06-25 PubMed ID: 24959734DOI: 10.2460/ajvr.75.7.668Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Randomized Controlled Trial

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research investigates how two non-steroidal anti-inflammatory drugs (NSAIDs), namely meloxicam and phenylbutazone, affect kidney function in horses, particularly in response to the drugs furosemide, dobutamine, and exercise.

Methodology

  • The research employs a randomized blinded placebo-controlled crossover study involving nine Thoroughbred or Standardbred mares aged between 2 to 12 years.
  • Each horse was subjected to three treatments – phenylbutazone, meloxicam, or a placebo – to evaluate their renal responses to applications of furosemide, dobutamine, and exercise for 15 minutes at 60% of their maximum heart rate.
  • The renal function was assessed by bilaterally catheterizing the ureters for simultaneous determination of creatinine clearance, sodium excretion, and urine flow rate.

Results

  • Both phenylbutazone and meloxicam were found to reduce the effects of diuresis (increased or excessive production of urine) and natriuresis (excretion of sodium in the urine) prompted by furosemide. This also led to a reduction in the glomerular filtration rate, which is a test to measure the level of kidney function and determine the stage of kidney disease.
  • After administering dobutamine or conducting exercise, the mean arterial blood pressure, urine flow rate, and glomerular filtration rate were increased.
  • Both NSAIDs resulted in reduced urine flow rate and sodium excretion associated with dobutamine infusion and exercise, but these did not impact the glomerular filtration rate.

Conclusion

  • The responses to meloxicam, a drug that prefers cyclooxygenase (COX)-2, seemed similar to those from phenylbutazone treatment. This suggests that COX-2 was responsible for causing prostanoid-induced changes to renal function in horses. It further implies that COX-2-preferential agents could potentially have adverse renal effects similar to nonselective COX inhibitors, particularly in horses suffering from volume depletion.

Cite This Article

APA
Raidal SL, Hughes KJ, Charman AL, Nielsen SG, Phillips JK, Noble GK. (2014). Effects of meloxicam and phenylbutazone on renal responses to furosemide, dobutamine, and exercise in horses. Am J Vet Res, 75(7), 668-679. https://doi.org/10.2460/ajvr.75.7.668

Publication

ISSN: 1943-5681
NlmUniqueID: 0375011
Country: United States
Language: English
Volume: 75
Issue: 7
Pages: 668-679

Researcher Affiliations

Raidal, Sharanne L
  • Schools of Animal and Veterinary Sciences, Charles Sturt University, Wagga Wagga, NSW 2650, Australia.
Hughes, Kris J
    Charman, Amanda-Lee
      Nielsen, Sharon G
        Phillips, Jacqueline K
          Noble, Glenys K

            MeSH Terms

            • Animals
            • Anti-Inflammatory Agents, Non-Steroidal / administration & dosage
            • Anti-Inflammatory Agents, Non-Steroidal / pharmacology
            • Cardiotonic Agents / administration & dosage
            • Cardiotonic Agents / pharmacology
            • Cross-Over Studies
            • Cyclooxygenase 2 / metabolism
            • Diuretics / pharmacology
            • Dobutamine / administration & dosage
            • Dobutamine / pharmacology
            • Female
            • Furosemide / administration & dosage
            • Furosemide / pharmacology
            • Glomerular Filtration Rate / drug effects
            • Horses / physiology
            • Kidney / drug effects
            • Kidney / physiology
            • Male
            • Meloxicam
            • Phenylbutazone / administration & dosage
            • Phenylbutazone / pharmacology
            • Physical Conditioning, Animal / physiology
            • Sodium / pharmacology
            • Thiazines / administration & dosage
            • Thiazines / pharmacology
            • Thiazoles / administration & dosage
            • Thiazoles / pharmacology